Jan Einhorn

VA New Jersey Health Care System — United States

Immunology and Microbiology · Life Sciences

8h-index3.8kcitations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(6), Multiple and Secondary Primary Cancers(6), Cancer survivorship and care(4), Cancer Treatment and Pharmacology(4), Management of metastatic bone disease(3)

Publications26 total

Patient-Reported Outcomes for Determining Prognostic Groups in Veterans With Advanced Cancer
Journal of Pain and Symptom Management·2015· 8 citedOpen Access
Patient-reported outcomes for determining prognostic groups in veterans with stage IV solid tumors starting systemic therapy.
Journal of Clinical Oncology·2014
Comparison of veterans diagnosed with left and right colon cancer over a period of 10 years.
Journal of Clinical Oncology·2014
Incidence of second primary malignancies in veterans after prostate cancer diagnosis.
Journal of Clinical Oncology·2014
Comparison of survival predictors in colorectal cancer (CRC) patients of different races.
Journal of Clinical Oncology·2013
Patient-reported outcomes for determining prognostic groups in veterans with stage IV solid tumors starting systemic therapy.
Journal of Clinical Oncology·2013
Patient-reported KPS and other measures as predictors of survival in patients with advanced cancer.
Journal of Clinical Oncology·2012· 1 cited
Comorbidity and survival in veterans with non-Hodgkin's lymphoma (NHL).
Journal of Clinical Oncology·2012
Comorbidity and other predictors of survival in veterans with colorectal cancer (CRC).
Journal of Clinical Oncology·2012
The Gleason score (GS) as a predictor of survival in stage D2 and D3 prostate cancer (PC).
Journal of Clinical Oncology·2011
Comparison of outcomes of patients with hepatocellular carcinoma (HCC) over 2 consecutive decades for a VA population.
Journal of Clinical Oncology·2011
Multidimensional model of hope and survival in patients with advanced cancer.
Journal of Clinical Oncology·2011· 1 cited
Patient-reported outcomes for determining prognostic groups in veterans with advanced cancer.
Journal of Clinical Oncology·2010
Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
Journal of Clinical Oncology·2009
Comorbidity and survival of hepatocellular carcinoma patients at a VA medical canter
Journal of Clinical Oncology·2009
Non-Hodgkin’s lymphoma patients at a VA medical center: Co-morbidity and its impact on survival
Journal of Clinical Oncology·2008
Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine
The Journal of Immunology·1999· 185 citedOpen Access
Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b
Journal of Clinical Oncology·1999· 316 cited
Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens
JNCI Journal of the National Cancer Institute·1998· 305 citedOpen Access
Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens
JNCI Journal of the National Cancer Institute·1998· 17 cited
page 1 of 2Next →

Frequent Co-authors

Victor T. Chang(15), Basil Kasimis(15), Barbara Crump(11), Melanie L. Gonzalez(9), Fengming Zhong(9), Donald E. White(8), Steven A. Rosenberg(7), James Chih‐Hsin Yang(7), Suzanne L. Topalian(7), Claudia A. Seipp(7), M. L. González(7), Douglas J. Schwartzentruber(6), Charles Scott(6), M. McPherson(5), Emma R Paz-Querubin(5), Maryann Sullivan(5), Nicholas P. Restifo(4), Houling Yan(4), J. Cogswell(4), Patrick Hwu(3)